Literature DB >> 29635107

Cytokine induced killer cells-assisted delivery of chlorin e6 mediated self-assembled gold nanoclusters to tumors for imaging and immuno-photodynamic therapy.

Fangfang Xia1, Wenxiu Hou1, Yanlei Liu1, Wentao Wang2, Yu Han1, Meng Yang1, Xiao Zhi1, Chenlu Li1, Daizong Qi1, Tianliang Li1, Jesus Martinez de la Fuente3, Chunlei Zhang1, Jie Song4, Daxiang Cui5.   

Abstract

The cytotoxicity and unique tumor-tropic properties of cytokine-induced killer (CIK) cells render them promising in the field of cancer immunotherapy and delivery systems. Here, we report a novel and facile approach to assemble gold nanoclusters (GNCs) into stable and monodispersed nanoparticles (NPs) using Chlorin e6 (Ce6) molecules. Notably, the fluorescence intensity of the GNCs-Ce6 NPs was about 4.5 folds stronger than the GNCs counterparts. The as-prepared GNCs-Ce6 NPs were conjugated with CD3 antibody (Ab) and further employed to label CIK cells to create a CIK cell-based drug delivery system (Ce6-GNCs-Ab-CIK). The Ce6-GNCs-Ab-CIK exhibited high tumor-targeting efficiency and excellent therapeutic efficacy toward MGC-803 tumor-bearing mice. Benefiting from the synergistic therapeutic effect between GNCs-Ce6-Ab NPs and CIK cells, the GNCs-Ce6-Ab-CIK strategy may present an ideal cancer theranostic platform for tumor targeted imaging and combination therapy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CIK cells; Chlorin e6; Gold nanoclusters; Immunotherapy; Near-infrared fluorescence imaging; Photodynamic therapy

Mesh:

Substances:

Year:  2018        PMID: 29635107     DOI: 10.1016/j.biomaterials.2018.03.048

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer.

Authors:  Virginia Del Solar; María Contel
Journal:  J Inorg Biochem       Date:  2019-07-18       Impact factor: 4.155

Review 2.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

3.  Blood Plasma Stabilized Gold Nanoclusters for Personalized Tumor Theranostics.

Authors:  Greta Jarockyte; Vilius Poderys; Virginijus Barzda; Vitalijus Karabanovas; Ricardas Rotomskis
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

4.  Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release.

Authors:  Xiangyan Chen; Wenwei Han; Xia Zhao; Wei Tang; Fahe Wang
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

5.  Developing cerium modified gold nanoclusters for the treatment of advanced-stage rheumatoid arthritis.

Authors:  Sen Lin; Wei Gao; Jiachen Sun; Kai Gao; Dan Li; Xifan Mei
Journal:  Mater Today Bio       Date:  2022-06-23

6.  Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy.

Authors:  Bin Liu; Wen Cao; Jin Cheng; Sisi Fan; Shaojun Pan; Lirui Wang; Jiaqi Niu; Yunxiang Pan; Yanlei Liu; Xiyang Sun; Lijun Ma; Jie Song; Jian Ni; Daxiang Cui
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

7.  Gastric Parietal Cell and Intestinal Goblet Cell Secretion: a Novel Cell-Mediated In Vivo Metal Nanoparticle Metabolic Pathway Enhanced with Diarrhea Via Chinese Herbs.

Authors:  Yanlei Liu; Kunlu Liu; Meng Yang; Yue Han; Qian Zhang; João Conde; Yuming Yang; Gabriel Alfranca; Yuxia Wang; Lijun Ma; Yingge Zhang; Jie Song; Yunxiang Pan; Jian Ni; Daxiang Cui
Journal:  Nanoscale Res Lett       Date:  2019-03-05       Impact factor: 4.703

Review 8.  Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment.

Authors:  Piotr Gierlich; Ana I Mata; Claire Donohoe; Rui M M Brito; Mathias O Senge; Lígia C Gomes-da-Silva
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.